Unlike ACL, this product is a refinement of the delivery of an existing well established treatment. It is not a new drug. the only issue is the safety of the delivery method which has been shown but needs further evidential support for the FDA (and possibly other regulatory bodies). IMO
Unlike ACL, this product is a refinement of the delivery of an...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.015(1.27%) |
Mkt cap ! $22.58M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.17 | $25.68K | 21.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 10490 | 4 |
View Market Depth
| Last trade - 15.42pm 17/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |